Triage Panel for Drugs of Abuse, Plus Tricyclic Antidepressants and Other Triage Drug Tests
Enzyme Immunoassay, Amphetamine. 510(k) K973784, from Biosite Incorporated (San Diego, CA). Product code DKZ, class 2.
As of Nov 19, 2026, K973784 is an FDA 510(k) held by Biosite Incorporated, substantially equivalent on Dec 3, 1997 after 61 days, with 4 recalls tied to it in FDA's recall database.
- Review time: 61 days
- Recalls: 4
- Cited as a predicate by: 3 devices
The Triage® Panel for Drugs of Abuse plus Trycyclic Antidepressants - Opiates 2000 (and other forms of the product) is an immunoassay used for the qualitative determination of the presence of the major metabolites of drugs of abuse, Phencyclidine, Benzodiazepines, Cocaine Metabolite, Amphetamines, THC, Opiates, Barbiturates, and Tricyclic Antidepressants in urine.
- Wound Flush, Sterile Water & Normal SalineK083042 · Nurse Assist, Inc. · Dec 18, 2008
- Triage Tox Drug Screen, Model 94400K060791 · Biosite Incorporated · Jun 22, 2006
- Ontrak Testcard 9K012396 · Roche Diagnostics Corp. · Nov 5, 2001
| Nov 14, 2017 | Z-0418-2018The recalled lots have demonstrated unexpected false positive THC results. | Completed |
| Jan 4, 2012 | Z-1130-2012Alere San Diego received a rise in customer complaints regarding false positive Barbiturates (BAR) results on the Triage Drugs of Abuse Panel Plus TCA. | Terminated |
| Jul 1, 2011 | Z-0521-2012The recall was initiated because Alere San Diego has confirmed false positive THC results obtained on Triage Drugs of Abuse Plus TCA 25 devices from lots 235991 and 238928. | Terminated |
| Nov 6, 2008 | Z-1088-2009The recall was initiated after the firm's investigations confirmed that, while lot #186625 passed all internal specifications and quality requirements, the incidence of false positive PCP results has exceeded their post… | Terminated |
- DRI Ecstasy Plus AssayK240670 · Microgenics Corporation · Oct 30, 2024
- AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest…K233019 · Hangzhou AllTest Biotech Co., Ltd. · Dec 13, 2023
- Xenta Drug Screen Cup, Xenta Drug Screen DipcardK231137 · Xenta Biomedical Science Co., Ltd. · May 19, 2023
- Type
- Traditional
- Received
- Oct 3, 1997
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files